Non-Surgical Treatments is fastest growing segment fueling the growth of Anal Fissure Treatment Market
![]() |
Anal Fissure Treatment Market |
The global Anal Fissure Treatment
Market is estimated to be valued at US$
1,039.3 Mn in 2023 and is expected to exhibit a CAGR of 5.3% over the forecast period 2023 to 2030, as highlighted
in a new report published by Coherent Market Insights.
Market Overview:
Anal fissure is a tear in the
lining of the anal canal. It causes symptoms like pain or bleeding during and
after bowel movements. The main aim of treatment is to relieve pain and promote
healing of the anal fissure. Non-surgical treatments like calcium channel
blockers, nitrates and Botox injections are becoming increasingly popular due
to quick relief and fewer side effects.
Market key trends:
One of the major trends driving
the market growth is the increasing preference for non-surgical treatments over
surgical methods. Non-surgical treatments like calcium channel blockers such as
diltiazem and nifedipine have shown promising results in pain relief and
fissure healing. Also, Botox injections help relax internal sphincter muscle
and increase blood supply to promote healing. In addition, advances in drug
delivery systems such as submucosal injection technique have minimized
procedure related pain and improved clinical efficacy of Botox treatment. Such
innovations are boosting the adoption of non-surgical treatments among patients
and physicians.
Segment Analysis
The global anal fissure treatment
market is dominated by the topical drugs sub segment due to ease of use and
availability in both prescription as well as over-the-counter drugs. Topical
drugs avoid the use of invasive procedures, thus enabling faster recovery and
relief from anal fissure symptoms.
Key Takeaways
The Global
Anal Fissure Treatment Market Size is expected to witness high growth,
exhibiting CAGR of 5.3% over the forecast period, due to increasing incidence
of anal fissure cases owing to rising bowel issues.
Regional analysis
North America is expected to
dominate the global anal fissure treatment market over the forecast period due
to growing awareness regarding anal fissure treatments and favorable
reimbursement policies in the region.
Key players
Key players operating in the anal
fissure treatment market are Allergan, Novartis, Pfizer, Takeda Pharmaceutical
Company, Cook Medical, Medtronic, Johnson & Johnson, AstraZeneca, GlaxoSmithKline,
Sanofi, Merck, Abbott Laboratories, Bayer, Astellas Pharma, Aurobindo Pharma,
Ferring Pharmaceuticals, Salix Pharmaceuticals, Eli Lilly, Bristol-Myers
Squibb, Boehringer Ingelheim.
Get More Insights Here
https://www.newsstatix.com/anal-fissure-treatment-market-size-share-growth-outlook-2023/
Comments
Post a Comment